(Q34282486)

1 August 2017

title

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry (English)

1 reference

1 August 2017

5

George Sgouros

1 reference

1 August 2017

2

Robert F Hobbs

1 reference

1 August 2017

1

Sébastien Baechler

1 reference

1 August 2017

Andrew R Prideaux

3

1 reference

1 August 2017

Richard L Wahl

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

1 August 2017

1 reference

1 August 2017

volume

35

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

1123-1134

1 reference

Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Relevance of external beam dose-response relationships to kidney toxicity associated with radionuclide therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Renal toxicity after radionuclide therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Is the Renal Dosimetry for [90Y-DOTA0, Tyr3]Octreotide Accurate Enough to Predict Thresholds for Individual Patients?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Proliferation and the advantage of longer-lived radionuclides in radioimmunotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Dose-rate effects in targeted radiotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Bone marrow dosimetry for radioimmunotherapy: theoretical considerations.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

A graphical method to simplify the application of the linear-quadratic dose-effect equation to fractionated radiotherapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

The linear-quadratic formula and progress in fractionated radiotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Tolerance of normal tissue to therapeutic irradiation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Application of the linear-quadratic model with incomplete repair to radionuclide directed therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy

6 July 2018

1 reference

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

21 January 2018

1 reference

The assessment of RBE effects using the concept of biologically effective dose.

21 January 2018

1 reference

Clinical implications of heterogeneity of tumor response to radiation therapy

21 January 2018

1 reference

Spatial distribution of blood vessels and CD34+ hematopoietic stem and progenitor cells within the marrow cavities of human cancellous bone.

21 January 2018

1 reference

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

21 January 2018

1 reference

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotide.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974633

Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides

28 October 2018

1 reference

12 December 2020

MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee

1 reference

12 December 2020

The radiobiology of conventional radiotherapy and its application to radionuclide therapy

1 reference

12 December 2020

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

12 December 2020

Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy

1 reference

12 December 2020

Effects of cellular repair and proliferation on targeted radionuclide therapy: a modelling study

1 reference

12 December 2020

Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy

1 reference

12 December 2020

Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings

1 reference

12 December 2020

The nonuniformity of antibody distribution in the kidney and its influence on dosimetry

1 reference

12 December 2020

MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney

1 reference

12 December 2020

Application of the linear-quadratic model to combined modality radiotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1118/1.2836421

1 reference

1 August 2017

1 reference

1 August 2017

1 reference